BOLT - Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08 revenue of $1.39M beats by $0.89M August, 10 2022 04:57 PM Bolt Biotherapeutics Inc. Bolt Biotherapeutics press release ( NASDAQ: BOLT ): Q2 GAAP EPS of -$0.61 beats by $0.08 . Revenue of $1.39M beats by $0.89M . For further details see: Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08, revenue of $1.39M beats by $0.89M